What is Fujian Aonong Biological Technology Grouporp Financial Strength?
Fujian Aonong Biological Technology Grouporp has the Financial Strength Rank of 2. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Warning Sign:
Fujian Aonong Biological Technology Group Incorp Ltd displays poor financial strength. Usually, this is caused by too much debt for the company.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
Fujian Aonong Biological Technology Grouporp did not have earnings to cover the interest expense.
Fujian Aonong Biological Technology Grouporp's debt to revenue ratio for the quarter that ended in Mar. 2024 was 0.84.
As of today, Fujian Aonong Biological Technology Grouporp's Altman Z-Score is -0.81.
Competitive Comparison of Fujian Aonong Biological Technology Grouporp's Financial Strength
For the Farm Products subindustry, Fujian Aonong Biological Technology Grouporp's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fujian Aonong Biological Technology Grouporp's Financial Strength Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Fujian Aonong Biological Technology Grouporp's Financial Strength distribution charts can be found below:
* The bar in red indicates where Fujian Aonong Biological Technology Grouporp's Financial Strength falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Fujian Aonong Biological Technology Grouporp has a Z-score of -0.81, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -0.81 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Fujian Aonong Biological Technology Grouporp has the Financial Strength Rank of 2. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Fujian Aonong Biological Technology Grouporp Financial Strength Related Terms
Thank you for viewing the detailed overview of Fujian Aonong Biological Technology Grouporp's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Fujian Aonong Biological Technology Grouporp (SHSE:603363) Business Description
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:603363 has been successfully added to your